title: Age-specific characteristics of the basal insulin-rate for pediatric patients on CSII.
abstract: OBJECTIVE
  This study intends to analyse the basal insulin dosage for pediatric patients (0-18 years) with type 1 diabetes on insulin-pump therapy (CSII).
  
  
  METHODS
  In a large German and Austrian prospectively documented data base (DPV) for children with diabetes, patients with CSII were identified. The documented basal rates from patients (0-18 years) were analysed and related to age, gender, duration of diabetes, body weight and type of insulin used in the pump. Data were evaluated for three age groups (0-6; >6-12; >12-18 years).
  
  
  RESULTS
  Complete data sets with documented hourly intervals of basal rate were available from 743 patients. Basal insulin dosage in the 3 age groups differed significantly (0-6 years 0.20 IU/kg body weight; >6-12 years 0.34 IU/kg body weight; >12-18 years 0.41 IU/kg body weight p<0.0001). The amount of basal insulin in 24 hours in each group correlates with body weight, age and duration of diabetes. The circadian distribution of the basal rate shows different profiles in each age group.
  
  
  CONCLUSIONS
  Pediatric patients on CSII have age specific characteristics in total amount and circadian distribution of basal rates.
authors.affiliation: Pediatric Practice, Herford, Germany. dr.klinkert@t-online.de
authors.forename: C
authors.initials: C
authors.lastname: Klinkert
authors.forename: R
authors.initials: R
authors.lastname: Bachran
authors.forename: B
authors.initials: B
authors.lastname: Heidtmann
authors.forename: M
authors.initials: M
authors.lastname: Grabert
authors.forename: R W
authors.initials: RW
authors.lastname: Holl
mesh_terms: D000293:Adolescent; D000367:Age Factors; D002648:Child; D002675:Child, Preschool; D016208:Databases, Factual; D003922:Diabetes Mellitus, Type 1 / Q000188:drug therapy*; D004305:Dose-Response Relationship, Drug; D005260:Female; D006442:Glycated Hemoglobin / Q000032:analysis; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D007328:Insulin / Q000008:administration & dosage / Q000031:analogs & derivatives*; D007332:Insulin Infusion Systems; D049528:Insulin, Long-Acting; D008297:Male
chemical_list: D006442:Glycated Hemoglobin; D007328:Insulin; D049528:Insulin, Long-Acting; C517652:hemoglobin A1c protein, human